Arsenal Capital Partners

Type

Private equity

Status

Active

Location

New York, United States

Total investments

10

Average round size

52M

Portfolio companies

8

Rounds per year

0.43

Lead investments

4

Follow on index

0.10

Exits

2

Areas of investment
BiotechnologySoftwareFinTechAnalyticsHealth CareHealth DiagnosticsHospitalMobile PaymentsPharmaceuticalClinical Trials

Summary

Arsenal Capital Partners is the famous VC, which was founded in 2000. The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.

The fund has no exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Aptimmune, KEW Group For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Health Diagnostics, Therapeutics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

The fund is constantly included in less than 2 investment rounds annually. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2016. Deals in the range of 5 - 10 millions dollars are the general things for fund.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Arsenal Capital Partners, startups are often financed by Arch Grants, The Bolyston Street Group, Cardinal Health. The meaningful sponsors for the fund in investment in the same round are Signet Healthcare Partners, Jim Eberlin, Illinois Ventures. In the next rounds fund is usually obtained by The Yield Lab, Arsenal Capital Management, St. Louis Arch Angels.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
10
Lead investments
4
Exits
2
Rounds per year
0.43
Follow on index
0.10
Investments by industry
  • Health Care (7)
  • Biotechnology (4)
  • Health Diagnostics (3)
  • Analytics (2)
  • Pharmaceutical (2)
  • Show 11 more
Investments by region
  • United States (8)
  • France (1)
Peak activity year
2022
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
14
Avg. valuation at time of investment
437M
Group Appearance index
0.60
Avg. company exit year
9
Avg. multiplicator
4.17
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Juristat 05 Jan 2015 Analytics, Big Data, Legal Seed 1M United States, Missouri, City of Saint Louis
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.